News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Daiichi Sankyo, Inc. (4568.t) To Help Ranbaxy Laboratories (RANBAXY.BO) Meet FDA Norms



12/19/2013 7:07:51 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Japanese pharmaceutical major Daiichi Sankyo has said that it will extend assistance to Ranbaxy's plants in India hit by US quality sanctions to upgrade their standard. In a meeting with Commerce & Industry Minister Anand Sharma on Thursday, Daiichi Sankyo's President & CEO, George Nakayama, said that the company will give technical assistance to Ranbaxy to comply with norms, according to a Commerce Ministry official. Daiichi, which owns a controlling stake in Ranbaxy, will focus on the company's plant in Mohali which is the latest to be hit by US FDA sanctions following which exports from the unit to the US has been banned.

Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES